Acetyl-l-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery

Neuroscience

Volumn 210, Issue , 2012, Pages 296-307

  Patel, S P ^a   Sullivan, P G ^a   Lyttle, T S ^a   Magnuson, D S K ^b   Rabchevsky, A G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Central pattern generator; L1 L2 SCI; Locomotor function; Locomotor neuronal circuitry; Mitochondrial bioenergetics; Neuroprotection

Indexed keywords

CHOLINE ACETYLTRANSFERASE; LEVACECARNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CONTUSION; FEMALE; FUNCTIONAL STATUS; GRAY MATTER; HINDLIMB; LIMB MOVEMENT; LUMBAR SPINAL CORD; MITOCHONDRIAL RESPIRATION; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; SPINAL CORD VENTRAL HORN; WEIGHT BEARING; WHITE MATTER;

ACETYLCARNITINE; ANIMALS; ENERGY METABOLISM; FEMALE; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 84861200993     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.006     Document Type: Article

References (106)

1. Akdemir H., Pasaoglu H., Arman F., Coksevim B., Pasaoglu A. Effects of TRH and high-dose corticosteroid therapy on evoked potentials, and tissue Na+, K+ and water content in experimental spinal injury. Res Exp Med (Berl) 1993, 193:297-304.
2. Arafa H.M., Hemeida R.A., Hassan M.I., Abdel-Wahab M.H., Badary O.A., Hamada F.M. Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats. Basic Clin Pharmacol Toxicol 2009, 105:30-36.
3. Aureli T., Di Cocco M.E., Capuani G., Ricciolini R., Manetti C., Miccheli A., Conti F. Effect of long-term feeding with acetyl-L-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy. Neurochem Res 2000, 25:395-399.
4. Aureli T., Puccetti C., Di Cocco M.E., Arduini A., Ricciolini R., Scalibastri M., Manetti C., Conti F. Entry of [(1,2-13C2)acetyl]-L-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats. Eur J Biochem 1999, 263:287-293.
5. Azbill R.D., Mu X., Bruce-Keller A.J., Mattson M.P., Springer J.E. Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 1997, 765:283-290.
6. Baldwin S.A., Broderick R., Osbourne D., Waeg G., Blades D.A., Scheff S.W. The presence of 4-hydroxynonenal/protein complex as an indicator of oxidative stress after experimental spinal cord contusion in a rat model. J Neurosurg 1998, 88:874-883.
7. Bareyre F.M., Kerschensteiner M., Raineteau O., Mettenleiter T.C., Weinmann O., Schwab M.E. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat Neurosci 2004, 7:269-277.
8. Basso D.M., Beattie M.S., Bresnahan J.C., Anderson D.K., Faden A.I., Gruner J.A., Holford T.R., Hsu C.Y., Noble L.J., Nockels R., Perot P.L., Salzman S.K., Young W. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter animal Spinal Cord injury study. J Neurotrauma 1996, 13:343-359.
9. Behrmann D.L., Bresnahan J.C., Beattie M.S. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673. Exp Neurol 1994, 126:61-75.
10. Bertrand S., Cazalets J.R. The respective contribution of lumbar segments to the generation of locomotion in the isolated spinal cord of newborn rat. Eur J Neurosci 2002, 16:1741-1750.
11. Blass J.P., Gibson G.E. Studies of the pathophysiology of pyruvate dehydrogenase deficiency. Adv Neurol 1978, 21:181-189.
12. Bogaert Y.E., Sheu K.F., Hof P.R., Brown A.M., Blass J.P., Rosenthal R.E., Fiskum G. Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation. Exp Neurol 2000, 161:115-126.
13. Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol 1986, 24:511-516.
14. Bracken M.B. Methylprednisolone in the management of acute spinal cord injuries. Med J Aust 1990, 153:368.
15. Bracken M.B. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine 2001, 26:S47-S54.
16. Bracken M.B., Collins W.F., Freeman D.F., Shepard M.J., Wagner F.W., Silten R.M., Hellenbrand K.G., Ransohoff J., Hunt W.E., Perot P.L., et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984, 251:45-52.
17. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., Maroon J.C., Marshall L.F., et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second national acute Spinal Cord injury study. J Neurosurg 1992, 76:23-31.
18. Bracken M.B., Shepard M.J., Collins W.F., Holford T.R., Young W., Baskin D.S., Eisenberg H.M., Flamm E., Leo-Summers L., Maroon J., et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute Spinal Cord injury study. N Engl J Med 1990, 322:1405-1411.
19. Bracken M.B., Shepard M.J., Hellenbrand K.G., Collins W.F., Leo L.S., Freeman D.F., Wagner F.C., Flamm E.S., Eisenberg H.M., Goodman J.H., et al. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the national acute Spinal Cord injury study. J Neurosurg 1985, 63:704-713.
20. Bracken M.B., Shepard M.J., Holford T.R., Leo-Summers L., Aldrich E.F., Fazl M., Fehlings M., Herr D.L., Hitchon P.W., Marshall L.F., Nockels R.P., Pascale V., Perot P.L., Piepmeier J., Sonntag V.K., Wagner F., Wilberger J.E., Winn H.R., Young W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute Spinal Cord injury randomized controlled trial. National acute Spinal Cord injury study. JAMA 1997, 277:1597-1604.
21. Braughler J.M., Hall E.D. Involvement of lipid peroxidation in CNS injury. J Neurotrauma 1992, 9(Suppl 1):S1-S7.
22. Cazalets J.R., Borde M., Clarac F. Localization and organization of the central pattern generator for hindlimb locomotion in newborn rat. J Neurosci 1995, 15:4943-4951.
23. Cazalets J.R., Borde M., Clarac F. The synaptic drive from the spinal locomotor network to motoneurons in the newborn rat. J Neurosci 1996, 16:298-306.
24. Chikawa T., Ikata T., Katoh S., Hamada Y., Kogure K., Fukuzawa K. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes. J Neurotrauma 2001, 18:93-103.
25. Conta Steencken A.C., Stelzner D.J. Loss of propriospinal neurons after spinal contusion injury as assessed by retrograde labeling. Neuroscience 2010, 170:971-980.
26. Cowley K.C., Schmidt B.J. Regional distribution of the locomotor pattern-generating network in the neonatal rat spinal cord. J Neurophysiol 1997, 77:247-259.
27. De Meirleir L., Lissens W., Denis R., Wayenberg J.L., Michotte A., Brucher J.M., Vamos E., Gerlo E., Liebaers I. Pyruvate dehydrogenase deficiency: clinical and biochemical diagnosis. Pediatr Neurol 1993, 9:216-220.
28. Dhitavat S., Ortiz D., Shea T.B., Rivera E.R. Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res 2002, 27:501-505.
29. Di Cesare Mannelli L., Ghelardini C., Calvani M., Nicolai R., Mosconi L., Vivoli E., Pacini A., Bartolini A. Protective effect of acetyl-L-carnitine on the apoptotic pathway of peripheral neuropathy. Eur J Neurosci 2007, 26:820-827.
30. Di Cesare Mannelli L., Ghelardini C., Calvani M., Nicolai R., Mosconi L., Toscano A., Pacini A., Bartolini A. Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: A role for the nicotinic receptor. J Neurosci Res 2008, 87:200-207.
31. Diaz-Ruiz A., Rios C., Duarte I., Correa D., Guizar-Sahagun G., Grijalva I., Madrazo I., Ibarra A. Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. Neuroreport 2000, 11:1765-1767.
32. Elanchezhian R., Sakthivel M., Isai M., Geraldine P., Thomas P.A. Evaluation of lenticular antioxidant and redox system components in the lenses of acetyl-L-carnitine treatment in BSO-induced glutathione deprivation. Mol Vis 2009, 15:1485-1491.
33. El-Awady el S.E., Moustafa Y.M., Abo-Elmatty D.M., Radwan A. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. Eur J Pharmacol 2011, 650:335-341.
34. Farrell S., Vogel J., Bieber L.L. Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim Biophys Acta 1986, 876:175-177.
35. Finkel E. The mitochondrion: is it central to apoptosis?. Science 2001, 292:624-626.
36. Hadi B., Zhang Y.P., Burke D.A., Shields C.B., Magnuson D.S. Lasting paraplegia caused by loss of lumbar spinal cord interneurons in rats: no direct correlation with motor neuron loss. J Neurosurg 2000, 93:266-275.
37. Hall E.D. The neuroprotective pharmacology of methylprednisolone. J Neurosurg 1992, 76:13-22.
38. Hall E.D. Lipid antioxidants in acute central nervous system injury. Ann Emerg Med 1993, 22:1022-1027.
39. Hall E.D., Braughler J.M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and (Na+ + K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J Neurosurg 1982, 57:247-253.
40. Hall E.D., Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004, 1:80-100.
41. Hao J., Shen W., Sun L., Long J., Sharman E., Shi X., Liu J. Mitochondrial dysfunction in the liver of type 2 diabetic Goto-Kakizaki rats: improvement by a combination of nutrients. Br J Nutr 2011, 22:1-8.
42. Hota K.B., Hota S.K., Chaurasia O.P., Singh S.B. Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus 2012, 22:723-736.
43. Hou S., Duale H., Cameron A.A., Abshire S.M., Lyttle T.S., Rabchevsky A.G. Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection. J Comp Neurol 2008, 509:382-399.
44. Hunot S., Flavell R.A. Apoptosis. Death of a monopoly?. Science 2001, 292:865-866.
45. Hurlbert R.J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000, 93:1-7.
46. Jin Y., McEwen M.L., Nottingham S.A., Maragos W.F., Dragicevic N.B., Sullivan P.G., Springer J.E. The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord. J Neurotrauma 2004, 21:1396-1404.
47. Jones L.L., McDonald D.A., Borum P.R. Acylcarnitines: role in brain. Prog Lipid Res 2010, 49:61-75.
48. Kamencic H., Griebel R.W., Lyon A.W., Paterson P.G., Juurlink B.H. Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function. FASEB J 2001, 15:243-250.
49. Kido Y., Tamai I., Ohnari A., Sai Y., Kagami T., Nezu J., Nikaido H., Hashimoto N., Asano M., Tsuji A. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 2001, 79:959-969.
50. Kjaerulff O., Kiehn O. Distribution of networks generating and coordinating locomotor activity in the neonatal rat spinal cord in vitro: a lesion study. J Neurosci 1996, 16:5777-5794.
51. Koc R.K., Akdemir H., Karakucuk E.I., Oktem I.S., Menku A. Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord 1999, 37:29-32.
52. Kremer E., Lev-Tov A. Localization of the spinal network associated with generation of hindlimb locomotion in the neonatal rat and organization of its transverse coupling system. J Neurophysiol 1997, 77:1155-1170.
53. Ksiezak-Reding H., Peterson C., Gibson G.E. The pyruvate dehydrogenase complex during aging. Mech Ageing Dev 1984, 26:67-73.
54. Liu D., McAdoo D.J. Methylprednisolone reduces excitatory amino acid release following experimental spinal cord injury. Brain Res 1993, 609:293-297.
55. Lowitt S., Malone J.I., Salem A.F., Korthals J., Benford S. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 1995, 44:677-680.
56. Lucas J.H., Wheeler D.G., Guan Z., Suntres Z., Stokes B.T. Effect of glutathione augmentation on lipid peroxidation after spinal cord injury. J Neurotrauma 2002, 19:763-775.
57. Luo J., Borgens R., Shi R. Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J Neurotrauma 2004, 21:994-1007.
58. Magnuson D.S., Green D.M., Sengoku T. Lumbar spinoreticular neurons in the rat: part of the central pattern generator for locomotion?. Ann N Y Acad Sci 1998, 860:436-440.
59. Magnuson D.S., Lovett R., Coffee C., Gray R., Han Y., Zhang Y.P., Burke D.A. Functional consequences of lumbar spinal cord contusion injuries in the adult rat. J Neurotrauma 2005, 22:529-543.
60. Martin E., Rosenthal R.E., Fiskum G. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res 2005, 79:240-247.
61. McCullers D.L., Sullivan P.G., Scheff S.W., Herman J.P. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat. Neuroscience 2002, 109:219-230.
62. McEwen M.L., Sullivan P.G., Rabchevsky A.G., Springer J.E. Targeting mitochondrial function for the treatment of acute spinal cord injury. Neurotherapeutics 2011, 8:168-179.
63. McEwen M.L., Sullivan P.G., Springer J.E. Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats. J Neurotrauma 2007, 24:613-624.
64. Michel R.P., Cruz-Orive L.M. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc 1988, 150:117-136.
65. Musicco C., Capelli V., Pesce V., Timperio A.M., Calvani M., Mosconi L., Cantatore P., Gadaleta M.N. Rat liver mitochondrial proteome: changes associated with aging and acetyl-L-carnitine treatment. J Proteomics 2011, 74:2536-2547.
66. Ohashi R., Tamai I., Yabuuchi H., Nezu J.I., Oku A., Sai Y., Shimane M., Tsuji A. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999, 291:778-784.
67. Onofrj M., Fulgente T., Melchionda D., Marchionni A., Tomasello F., Salpietro F.M., Alafaci C., De Sanctis E., Pennisi G., Bella R., et al. L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Int J Clin Pharmacol Res 1995, 15:9-15.
68. Opii W.O., Nukala V.N., Sultana R., Pandya J.D., Day K.M., Merchant M.L., Klein J.B., Sullivan P.G., Butterfield D.A. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J Neurotrauma 2007, 24:772-789.
69. Paradies G., Ruggiero F.M., Gadaleta M.N., Quagliariello E. The effect of aging and acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria. Biochim Biophys Acta 1992, 1103:324-326.
70. Patel S.P., Sullivan P.G., Lyttle T.S., Rabchevsky A.G. Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury. J Neurochem 2010, 114:291-301.
71. Patel S.P., Sullivan P.G., Pandya J.D., Rabchevsky A.G. Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury. J Neurosci Res 2009, 87:130-140.
72. Pettegrew J.W., Levine J., McClure R.J. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry 2000, 5:616-632.
73. Pocernich C.B., Butterfield D.A. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 2003, 5:515-520.
74. Rabchevsky A.G., Fugaccia I., Fletcher-Turner A., Blades D.A., Mattson M.P., Scheff S.W. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J Neurotrauma 1999, 16:817-830.
75. Rabchevsky A.G., Fugaccia I., Sullivan P.G., Blades D.A., Scheff S.W. Efficacy of methylprednisolone therapy for the injured rat spinal cord. J Neurosci Res 2002, 68:7-18.
76. Rabchevsky A.G., Fugaccia I., Turner A.F., Blades D.A., Mattson M.P., Scheff S.W. Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat. Exp Neurol 2000, 164:280-291.
77. Rabchevsky A.G., Patel S.P., Springer J.E. Pharmacological interventions for spinal cord injury: where do we stand? How might we step forward?. Pharmacol Ther 2011, 132:15-29.
78. Rabchevsky A.G., Sullivan P.G., Scheff S.W. Temporal-spatial dynamics in oligodendrocyte and glial progenitor cell numbers throughout ventrolateral white matter following contusion spinal cord injury. Glia 2007, 55:831-843.
79. Rai G., Wright G., Scott L., Beston B., Rest J., Exton-Smith A.N. Double-blind, placebo controlled study of acetyl-L-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin 1990, 11:638-647.
80. Ravikumar R., McEwen M.L., Springer J.E. Post-treatment with the cyclosporin derivative, NIM811, reduced indices of cell death and increased the volume of spared tissue in the acute period following spinal cord contusion. J Neurotrauma 2007, 24:1618-1630.
81. Rebouche C.J. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004, 1033:30-41.
82. Richards E.M., Rosenthal R.E., Kristian T., Fiskum G. Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activity. Free Radic Biol Med 2006, 40:1960-1970.
83. Robertson C.L., Saraswati M., Fiskum G. Mitochondrial dysfunction early after traumatic brain injury in immature rats. J Neurochem 2007, 101:1248-1257.
84. Rosenthal P.B., Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J Mol Biol 2003, 333:721-745.
85. Ross I.B., Tator C.H. Spinal cord blood flow and evoked potential responses after treatment with nimodipine or methylprednisolone in spinal cord-injured rats. Neurosurgery 1993, 33:470-476. [Discussion:476-477].
86. Ross I.B., Tator C.H., Theriault E. Effect of nimodipine or methylprednisolone on recovery from acute experimental spinal cord injury in rats. Surg Neurol 1993, 40:461-470.
87. Sano M., Bell K., Cote L., Dooneief G., Lawton A., Legler L., Marder K., Naini A., Stern Y., Mayeux R. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch Neurol 1992, 49:1137-1141.
88. Scafidi S., Fiskum G., Lindauer S.L., Bamford P., Shi D., Hopkins I., McKenna M.C. Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. J Neurochem 2010, 114:820-831.
89. Scafidi S., Racz J., Hazelton J., McKenna M.C., Fiskum G. Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain. Dev Neurosci 2010, 32:480-487.
90. Sheu K.F., Kim Y.T., Blass J.P., Weksler M.E. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann Neurol 1985, 17:444-449.
91. Short D.J., El Masry W.S., Jones P.W. High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective. Spinal Cord 2000, 38:273-286.
92. Sorbi S., Bird E.D., Blass J.P. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 1983, 13:72-78.
93. Spagnoli A., Lucca U., Menasce G., Bandera L., Cizza G., Forloni G., Tettamanti M., Frattura L., Tiraboschi P., Comelli M., et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 1991, 41:1726-1732.
94. Springer J.E., Rao R.R., Lim H.R., Cho S.I., Moon G.J., Lee H.Y., Park E.J., Noh J.S., Gwag B.J. The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. J Neurotrauma 2010, 27:139-149.
95. Sullivan P.G., Krishnamurthy S., Patel S.P., Pandya J.D., Rabchevsky A.G. Temporal characterization of mitochondrial bioenergetics after spinal cord injury. J Neurotrauma 2007, 24:991-999.
96. Sullivan P.G., Rabchevsky A.G., Waldmeier P.C., Springer J.E. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?. J Neurosci Res 2005, 79:231-239.
97. Swamy-Mruthinti S., Carter A.L. Acetyl- L -carnitine decreases glycation of lens proteins: in vitro studies. Exp Eye Res 1999, 69:109-115.
98. Tempesta E., Casella L., Pirrongelli C., Janiri L., Calvani M., Ancona L. L-acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo. Drugs Exp Clin Res 1987, 13:417-423.
99. Tufekci O., Gunes D., Ozogul C., Kolatan E., Altun Z., Yilmaz O., Aktas S., Erbayraktar Z., Kirkim G., Mutafoglu K., Soylu A., Serbetcioglu B., Guneri E.A., Olgun N. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin nephrotoxicity. Chemotherapy 2009, 55:451-459.
100. Vaishnav R.A., Singh I.N., Miller D.M., Hall E.D. Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. J Neurotrauma 2010, 27:1311-1320.
101. Virmani A., Binienda Z. Role of carnitine esters in brain neuropathology. Mol Aspects Med 2004, 25:533-549.
102. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482-497.
103. Xiong Y., Singh I.N., Hall E.D. Tempol protection of spinal cord mitochondria from peroxynitrite-induced oxidative damage. Free Radic Res 2009, 43:604-612.
104. Xu J., Fan G., Chen S., Wu Y., Xu X.M., Hsu C.Y. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res Mol Brain Res 1998, 59:135-142.
105. Yu W.R., Liu T., Fehlings T.K., Fehlings M.G. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur J Neurosci 2009, 29:114-131.
106. Zaidan E., Sheu K.F., Sims N.R. The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. J Neurochem 1998, 70:233-241.